HomeNationWHO approves emergency use listing for Serum Institute of India manufactured Covovax

WHO approves emergency use listing for Serum Institute of India manufactured Covovax

@the_news_21

World Health Organisation (WHO) has issued an emergency use listing for Serum Institute of India’s manufactured Covovax. The move will help expand the basket of WHO-validated vaccines against the SARS-CoV-2 virus. In a statement, WHO said, the decision will give a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries.

The Serum Institute of India (SII) is producing Covovax under licence from Novavax and is part of the COVAX facility portfolio. Taking to Twitter, SII CEO Adar Poonawalla said, this is yet another milestone in our fight against Covid-19. He said, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy.

Subscribe to TheNews21

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

44 COMMENTS

  1. Solder together the millions winning strapping on play fanduel casino – the #1 natural money casino app in America.
    Pick up your $1000 PLAY IT AGAIN hand-out and turn every relate, хэнд and rotate into official banknotes rewards.
    Fast payouts, immense jackpots, and non-stop activity – download FanDuel Casino any longer and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

Html code here! Replace this with any non empty text and that's it.

Must Read

spot_img